This early-stage study will test a new vaccine concept using a genetically modified parasite to induce protection

Steve Davis calls for all sectors to prioritize efforts to better identify and stop outbreaks

Award from Federal Ministry of Education and Research to support effort to further optimize efficacy of RTS,S

Added to existing commitments from Gavi and UNITAID, WHO has the funding required to allow pilot implementation to move ahead in sub-Saharan Africa

Better tests for a common hereditary condition in humans are needed to facilitate treatment of Plasmodium vivax malaria

Top global health professionals meet to share the latest research and innovations around malaria, diarrhea, and other tropical diseases.

UNITAID funding decision expected later this summer

Dr. Laurence Slutsker to lead PATH’s malaria and neglected tropical diseases portfolios

Top global health professionals meet to share the latest research and innovations around malaria, pneumonia, and other tropical diseases

PATH & Tableau Foundation form unique partnership to aid elimination efforts in Zambia using data visualization

Decision paves the way for World Health Organization to assess how a malaria vaccine might be used in young children in sub-Saharan Africa

Final results from Phase III trial suggest substantial public health benefits could be provided by the RTS,S malaria vaccine candidate in endemic regions in sub-Saharan Africa; vaccine efficacy enhanced by administration of a booster dose

Events in the US, Belgium, and Zambia highlight collaborative efforts to end malaria deaths

New diagnostics for a common enzyme deficiency will bolster malaria elimination efforts

Grant from Gates Foundation to PATH Malaria Vaccine Initiative

First shipment marks a critical step in improving access to treatment worldwide

Dr. Rick King to lead work in transmission-blocking vaccines, evaluation technology

Events in Seattle and Berkeley, California, highlight progress and commitment toward eliminating malaria

Point-of-care diagnostic test seeks to improve management of P. vivax malaria

PATH staff will highlight our work to leverage new approaches and tools in the fight against malaria

Ashley Birkett, PhD, to lead key product development program at PATH

PATH staff will highlight our work in malaria control, treatment, and vaccine development

UK government is funding nine innovative partnerships to address deadly diseases

First non-plant-derived source of a key ingredient in the top malaria drug will increase access to treatment

A pivotal milestone in the fight against malaria

Follow-on agreement will lead to clinical trials

Campbell awarded American Society of Tropical Medicine and Hygiene prestigious LePrince Medal

Results from ongoing Phase III clinical trial announced

Briefing on successes of first five years, how to sustain progress

Events in Seattle and Washington, DC, highlight progress toward ending malaria deaths

PATH leaders discuss future directions in development of vaccines, prevention and control, and drug treatments